About this trial
The investigators hypothesize a relevant impact of cognitive status over gait performance in patients with amyotrophic lateral sclerosis (ALS), contributing to poor mobility and representing a relevant risk for falls. The present observational, cross-sectional study on ambulatory patients with ALS will evaluate gait performance using different sets of dual-task conditions to demonstrate the importance of cognitive aspects in rehabilitation programs for these patients. The dual-task conditions to be assessed during gait performance will include: counting backwards by 3 (executive simple task); counting backwards by 7 (executive complex task); mnemonic recall of the Rey's Auditory Verbal Learning Test (RAVLT). Patients' performance will be compared with a group of healthy controls with similar age and sex distribution in order to highlight the specific effects of the disease.
Eligibility criteria
Qualifiers
Age ≥ 18 years;
Clinical diagnosis of ALS or other MND phenotype;
Able to walk unassisted for at least 1 minute consecutively;
Oral and written informed consent to study participation.
Disqualifiers
Diagnosis of dementia;
Medical conditions or substance abuse that could interfere with cognition;
Any (other) major systemic, psychiatric, neurological, visual, and musculoskeletal disturbances or other causes of walking inability.
Trial design
Treatments tested in this trial
- Clinical and gait evaluation